EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    2.3.3.10 | Ketosis |
475 |
Fatty acid and ketone body metabolism in the rat: response to diet and exercise. |
unassigned |
0 |
| 2.3.3.10 | Ketosis |
1196305 |
Aspects of ketogenesis: control and mechanism of ketone-body formation in isolated rat-liver mitochondria. |
unassigned |
0 |
| 2.3.3.10 | Leukemia |
1346397 |
Calcium ionophore treatment impairs the sterol-mediated suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, 3-hydroxy-3-methylglutaryl-coenzyme A synthase, and farnesyl diphosphate synthetase. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 2.3.3.10 | Starvation |
1348927 |
Regulation of the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Its role in the control of ketogenesis. |
causal interaction
unassigned |
1
0 |
| 2.3.3.10 | Hypercholesterolemia |
1480917 |
[Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia] |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 2.3.3.10 | Carcinoma, Hepatocellular |
1627634 |
Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 2.3.3.10 | Hypercholesterolemia |
1685984 |
The effects of the intestinal glucosidase inhibitor acarbose on cholesterogenesis in corpulent rats. |
causal interaction
diagnostic usage
unassigned |
3
3
0 |
| 2.3.3.10 | Coronary Disease |
1899896 |
Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
3
4
0 |
| 2.3.3.10 | Dyslipidemias |
1940620 |
Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. |
diagnostic usage
therapeutic application
unassigned |
3
4
0 |
| 2.3.3.10 | Leukemia |
1968462 |
Isolation and sequence of the human farnesyl pyrophosphate synthetase cDNA. Coordinate regulation of the mRNAs for farnesyl pyrophosphate synthetase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and 3-hydroxy-3-methylglutaryl coenzyme A synthase by phorbol ester. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
